LATEST NEWS
- 01:32 PM Nifty extends gain on positive European cues; suga...
- 01:31 PM Infy to hire 20000 in FY11, says job scene improvi...
- 01:31 PM Above Rs 5115, Nifty can touch Rs 5150: Finquest S...
- 01:30 PM Below Rs 94, Mahindra Satyam can test Rs 85: Bhamb...
- 01:15 PM Buy banking, oil & gas stocks: G Shah
- 01:13 PM Nifty has resistance at 5120: HDFC Securities
- 01:00 PM Buy Dena Bank; target of Rs 88: India Infoline
- 12:54 PM Buy Sintex Ind; target of Rs 265: India Infoline
- 12:53 PM Wipro sees sustaining operating margins in near te...
- 12:51 PM Bajaj Hind to set up 5 power plants, stock up
Sun Pharma gets USFDA nod for Pantoprazole: Srcs
Published on Tue, Sep 11, 2007 at 09:40 | Updated at Tue, Sep 11, 2007 at 09:46 | Source : Moneycontrol.com
Sun Pharma has received USFDA nod to market Pantoprazole tablets, reports NW18. Pantoprazole is an anti-ulcer drug, with a US market of over USD1 billion. This drug is the generic version of Wyeth's Protonix.
More news from Business
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
WHAT OTHERS LIKE
-
Most Read
-
Most Viewed
24 Hours
7 Days
1 Month
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Sudarshan Sukhani's top five picks for today's trade
- Expert sector picks to power your portfolio ahead
- Ganeshaspeaks: Market prediction for Nov 25
- Mitesh Thacker's top 5 picks for trade today
- Ex-bonus, RIL will see correction: SP Tulsian
- Will ITC dream run continue beyond FY10?
- Mkts to remain strong; bet on midcaps: Ramesh Damani
- CBI catches top CLB official accepting Rs 6 lakh as bribe
NEWS FROM OUR PARTNERS
- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line
©Network 18, 2009. All Rights Reserved